0001237899-20-000006.txt : 20200128
0001237899-20-000006.hdr.sgml : 20200128
20200128170623
ACCESSION NUMBER: 0001237899-20-000006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200127
FILED AS OF DATE: 20200128
DATE AS OF CHANGE: 20200128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MURPHY ANDREW J
CENTRAL INDEX KEY: 0001796226
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 20555416
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-01-27
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001796226
MURPHY ANDREW J
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP Research
Common Stock
2020-01-27
4
S
0
200
336.78
D
57751
D
Common Stock
2020-01-27
4
S
0
270
337.46
D
57481
D
Common Stock
2020-01-27
4
S
0
712
338.54
D
56769
D
Common Stock
2020-01-27
4
S
0
567
339.37
D
56202
D
Common Stock
2020-01-27
4
S
0
1355
340.56
D
54847
D
Common Stock
2020-01-27
4
S
0
3283
341.58
D
51564
D
Common Stock
2020-01-27
4
S
0
1399
342.44
D
50165
D
Common Stock
2020-01-27
4
S
0
214
343.02
D
49951
D
Common Stock
4212
I
By 401(k) Plan
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 200 shares of Company stock on January 27, 2020 at prices ranging from $336.55 to $336.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price.
Represents volume-weighted average price of sales of 270 shares of Company stock on January 27, 2020 at prices ranging from $337.01 to $337.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price.
Represents volume-weighted average price of sales of 712 shares of Company stock on January 27, 2020 at prices ranging from $338.07 to $338.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price.
Represents volume-weighted average price of sales of 567 shares of Company stock on January 27, 2020 at prices ranging from $339.01 to $339.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,355 shares of Company stock on January 27, 2020 at prices ranging from $340.05 to $340.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price.
Represents volume-weighted average price of sales of 3,283 shares of Company stock on January 27, 2020 at prices ranging from $341.03 to $341.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,399 shares of Company stock on January 27, 2020 at prices ranging from $342.00 to $342.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price.
Represents volume-weighted average price of sales of 214 shares of Company stock on January 27, 2020 at prices ranging from $343.00 to $343.02. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price.
/s/**Andrew Murphy
2020-01-28